the tumorsuppressor protein p53.
Lysine acetylation is a long-known posttranslational modification (PTM) of proteins, which has recently entered center stage as important regulator of protein structure and function. 1 Initially discovered on histones, many more acetylated proteins were 15 found in eukaryotic and prokaryotic proteomes, rendering lysine acetylation as one of the most abundant PTMs in nature. 1 Lysine acetylation is introduced by lysine acetyl-transferases and removed by lysine or histone deacetylases (HDACs).
2-5 The latter class of enzymes has gained considerable attention because they 20 have been established as promising drug targets for a wide range of diseases including cancer. 6, 7 Especially the eleven mammalian HDACs of class I, II and IV (hereafter referred to as HDACs) are in the focus of biomedical research. 6, 7 These enzymes require Zn 2+ for catalysis and cleave the acetyl groups in a hydrolytic 25 reaction. Despite their medicinal importance, little is known about the substrate selectivity and catalytic properties of these enzymes due to the poor accessibility and activity of recombinant HDACs. 8, 9 However, in contrast to most recombinant enzymes, endogenous HDACs produced by mammalian cells are active. 8 A
30
wide range of deacetylase-assays was developed, but most of them are incompatible with the small amounts of endogenous HDACs which can be isolated from mammalian cells by standard techniques of molecular biology. [10] [11] [12] [13] [14] For example colorimetric readouts usually require reaction volumes >100 µL. 10 In addition 35 several proteins possess acetylation sites in close proximity and only very few assays are capable of multi-site readout of HDAC activity. 15 Based on this we planned to develop a quantitative and miniaturized readout strategy for endogenous HDAC activity, which is compatible with established methods of molecular 40 biology. Furthermore, the detection method should be able to monitor more than one modification site. To this end we resorted to MALDI-TOF-based mass spectrometry (MS). Mass spectrometry requires much less material for analysis than most other detection techniques. However, differences in the ionization 45 yield of educt and deacetylated product resulting from the presence or absence of this charge-altering PTM, will likely perturb the MS analysis. [16] [17] [18] human HDAC which can be produced in active form in E. coli.
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Recombinant HDAC8 is able to deacetylate K382ac of the tumorsupressor protein p53 (Fig. 1a ) and the enzyme was reported to be more active when supplied with Co 2+ instead of the canonical Zn
2+
. 22 We synthesized a peptide derived from the C-70 terminal region of p53 (378-386) covering the acetylation site at K382 (p53K382ac) as well as an isotopic coded reference of the deacetylated product containing homogenously 13 C-and 15 Nlabeled lysine at position 381 (p53K382(iso)) (Table S1 ESI). Recombinant HDAC8 was incubated with p53K382ac in 75 presence of either Co 2+ or Zn 2+ and after stopping the reaction by adding the pan-specific HDAC inhibitor trichostatin A (TSA) the mixture was supplied with p53K382(iso) and analyzed by MALDI-TOF. The expected signals of deacetylated product, isotopic coded reference and starting material were readily 80 detected and the deacetylation rates were calculated from the signal intensities (Fig. S1 ESI) . The analysis showed that recombinant HDAC8 was approximately 10-fold more active in presence of Co 2+ compared to Zn 2+ (Fig. 1b) . Consequently, we used Co 2+ instead of Zn 2+ for all further assays with recombinant HDAC8. In the following we compared the MALDI-TOF readout with a conventional HPLC-based assay. Nearly identical deacetylation rates were determined with both methods, indicating that the MALDI-TOF readout in combination with isotopic coded references is suitable for analyzing HDAC activity (Fig. 1c) .
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Encouraged by these findings we investigated the substrate selectivity of HDAC8 in more detail. There are only a few other described substrates of recombinant HDAC8. One of them is the acetyltion site at lysine 20 of histone H4. 15 Both, p53K382ac and H4K20ac share a homologous sequence context (R-H-R/K-Kac-30 V/L). It is not clear if these sites are somehow connected in a physiological context, but it appears likely that the amino acids flanking the acetylation sites support the substrate recognition by HDAC8 (Fig. 1a) . 23 The tumorsupressor p53 possesses several acetylation sites and we asked if sites other than K382ac might 35 represent HDAC8 substrates. 24 Two sites were of particular interest: p53K373ac and p53K320ac which share limited similarities with the basic N-terminal region of p53K382ac and H4K20ac (Fig. 1a) . We synthesized acetylated peptides derived from both sites (p53K373ac and p53K320ac) as well as the 40 isotopic references (p53K373(iso) and p53K320(iso)). The kinetics confirmed that p53K382ac was efficiently deacetylated by HDAC8 (Fig. 1d) . The enzyme was also able to deacetylated p53K373ac, but with approximately 18-fold reduced rate. In contrast, no deacetylation of p53K320ac was observed within the 45 concentration range. These measurements indicate that the substrate selectivity profile of recombinant HDAC8 is rather narrow and that deacetylation rates correlate with the homology to the p53K382ac and H4K20ac sites (Fig. 1a) . Next, we focused on HDAC-substrates with more than one 50 acetylation site. The N-terminal tails of histones represent prime examples of hyper-acetylated peptides. Histone H4 contains acetylated K16 in addition to the above-mentioned K20ac site. However, K16ac of H4 does not belong to the reported substrates of HDAC8. 15 We synthesized a bis-acetylated peptide derived 55 from H4 containing K16ac and K20ac (H4K16acK20ac). In order to distinguish both sites, the acetyl group at K20ac was homogenously deuterium-and 13 C-coded, while the acetyl group at K16ac remained unlabeled (Fig. 2a) . Deacetylation of H4K16acK20ac results in mono-deacetylated and fully 60 deacetylated products and we synthesized the corresponding isotopic coded references H4K16acK20(iso) and H4K16K20(iso) (Fig. S2 ESI) . Recombinant HDAC8 removed K20ac efficiently, while K16ac was deacetylated slowly and only after complete removal of K20ac (Fig. 2b and S3a ESI). Pan-specific HDAC 65 inhibitor TSA blocked the reaction, as well as PCI-34051, which is a synthetic HDAC8-specific inhibitor. Encouraged by these findings we analyzed global HDAC activity in native HeLa extracts. H4K16acK20ac was mixed with wholecell HeLa extract and analyzed by MALDI-TOF. We observed 70 efficiently and simultaneous deacetylation of K20ac and K16ac. Global deacetylase activity was blocked by TSA but not by PCI-34051 ( Fig. 2c and S3b ESI). After the successful establishment of miniaturized multi-site readout of HDAC activity we focused on individual endogenous 75 enzymes from HeLa extracts. To this end we established a simple procedure for isolating and assaying HDACs from cellular lysates by immunoprecipitation (Fig. S4 ESI) . At first gel-loading tips were filled with antibody-binding protein A or protein G agarose, which remained in the tips during pipetting steps. In the 80 following anti-HDAC antibodies and subsequently HDACs were immobilized on the resin by pipetting antibody solutions and HeLa lysates. Next, H4K16acK20ac was loaded onto the resin and at selected intervals samples were eluted for MALDI-TOF analysis. We performed this procedure with recombinant HDAC8 85 and observed the expected preference for K20ac (Fig. 2d) .
However, when performing the reaction with the deacetylase activities that were immunoprecipitated from HeLa extracts with anti-HDAC1 and selected other anti-HDAC antibodies we observed simultaneous deacetylation of K20ac and K16ac, similar to the activity in whole-cell lysates (Fig. S5 ESI) . The 5 specific activity of endogenous HDACs remains unknown since the amounts and interaction partners of immobilized enzymes are very hard to determine, but the deacetylase activities associated with antibodies against HDACs 1 and 2 were most efficient in deacetylating H4K16acK20ac (Fig. 2e and S5 ESI) . These Finally, we also tested the generality of this approach by analyzing dephosphorylation reactions. Protein phosphatase 1 (PP1) is known to catalyze dephosphorylation of S10ph on 25 histone H3 and we studied this reaction with recombinant PP1α, an H3S10ph substrate and the corresponding H3S10(iso) reference (Fig. S6 ESI) . Kinetics and inhibition studies of PP1α with PP1-inhibitor microcystin-LR were performed and enabled determination of the kinetic parameters (Fig. S7 ESI) 
